AstraZeneca Pharma India Limited(IN:ASTRAZEN)
₹6,166.20+133.45 (+2.21%)
IN:ASTRAZEN
AstraZeneca Pharma India Limited financials statements
₹6,166.20
At close:+133.45 (+2.21%)
Want to see IN:ASTRAZEN full AI Analyst Report?
AstraZeneca Pharma India Limited (ASTRAZEN) Ratios
44 Followers
AstraZeneca Pharma India Limited Ratios
IN:ASTRAZEN's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:ASTRAZEN's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.77 | 1.91 | 2.61 | 2.18 | 2.12 |
| Quick Ratio | 0.73 | 1.13 | 1.97 | 1.68 | 1.70 |
| Cash Ratio | 0.46 | 0.76 | 1.42 | 1.30 | 1.35 |
| Solvency Ratio | 0.19 | 0.21 | 0.48 | 0.29 | 0.23 |
| Operating Cash Flow Ratio | 0.01 | 0.09 | 0.08 | 0.15 | 0.30 |
| Short-Term Operating Cash Flow Coverage | 0.49 | 0.00 | 15.40 | 16.56 | 27.92 |
| Net Current Asset Value | ₹ 6.24B | ₹ 5.95B | ₹ 5.67B | ₹ 4.39B | ₹ 3.60B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.02 | 0.00 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.13 | 0.05 | 0.01 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.11 | 0.04 | 0.01 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.28 | 1.97 | 1.51 | 1.67 | 1.67 |
| Debt Service Coverage Ratio | 11.99 | 107.66 | 59.02 | 28.00 | 17.43 |
| Interest Coverage Ratio | 51.99 | 147.13 | 142.86 | 236.33 | 73.32 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 46.06 | 14.88 | 2.32 | 3.14 | 3.83 |
| Net Debt to EBITDA | -1.18 | -2.53 | -2.13 | -3.27 | -4.36 |
| Profitability Margins | |||||
| Gross Profit Margin | 26.46% | 41.60% | 48.03% | 57.60% | 55.63% |
| EBIT Margin | 11.28% | 9.21% | 17.04% | 13.43% | 10.43% |
| EBITDA Margin | 12.54% | 11.55% | 18.19% | 15.05% | 12.53% |
| Operating Profit Margin | 10.26% | 12.54% | 13.23% | 14.84% | 8.65% |
| Pretax Profit Margin | 11.08% | 9.13% | 16.95% | 13.37% | 10.31% |
| Net Profit Margin | 8.24% | 6.76% | 12.47% | 9.90% | 7.65% |
| Continuous Operations Profit Margin | 8.24% | 6.76% | 12.47% | 9.90% | 7.65% |
| Net Income Per EBT | 74.35% | 74.02% | 73.57% | 74.04% | 74.18% |
| EBT Per EBIT | 108.03% | 72.79% | 128.06% | 90.07% | 119.22% |
| Return on Assets (ROA) | 9.43% | 7.62% | 14.98% | 10.08% | 7.19% |
| Return on Equity (ROE) | 21.49% | 15.02% | 22.69% | 16.87% | 12.05% |
| Return on Capital Employed (ROCE) | 23.18% | 26.35% | 23.78% | 24.78% | 13.29% |
| Return on Invested Capital (ROIC) | 17.00% | 19.36% | 17.41% | 18.13% | 9.73% |
| Return on Tangible Assets | 9.43% | 7.63% | 15.01% | 10.08% | 7.19% |
| Earnings Yield | 0.97% | 0.55% | 1.24% | 1.22% | 0.97% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.65 | 9.25 | 7.65 | 8.48 | 9.38 |
| Payables Turnover | 2.14 | 2.19 | 3.43 | 1.87 | 1.88 |
| Inventory Turnover | 1.63 | 1.82 | 2.95 | 2.24 | 2.55 |
| Fixed Asset Turnover | 19.37 | 26.95 | 19.98 | 14.29 | 10.50 |
| Asset Turnover | 1.14 | 1.13 | 1.20 | 1.02 | 0.94 |
| Working Capital Turnover Ratio | 3.26 | 2.82 | 2.52 | 2.43 | 2.34 |
| Cash Conversion Cycle | 87.63 | 73.08 | 64.71 | 10.72 | -12.36 |
| Days of Sales Outstanding | 34.27 | 39.45 | 47.70 | 43.06 | 38.91 |
| Days of Inventory Outstanding | 224.07 | 200.09 | 123.54 | 163.26 | 143.18 |
| Days of Payables Outstanding | 170.71 | 166.45 | 106.54 | 195.59 | 194.46 |
| Operating Cycle | 258.34 | 239.54 | 171.24 | 206.31 | 182.09 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.73 | 26.15 | 11.15 | 23.32 | 40.32 |
| Free Cash Flow Per Share | 1.28 | 25.45 | 6.84 | 19.91 | 36.47 |
| Dividend Paid and CapEx Coverage Ratio | 0.08 | 1.06 | 0.55 | 2.04 | 6.89 |
| Capital Expenditure Coverage Ratio | 1.89 | 37.35 | 2.59 | 6.84 | 10.48 |
| Operating Cash Flow Coverage Ratio | 0.06 | 1.83 | 6.07 | 8.08 | 11.68 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.04 | 0.02 | 0.06 | 0.13 |
| Free Cash Flow Yield | 0.02% | 0.30% | 0.13% | 0.61% | 1.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 103.53 | 183.43 | 80.50 | 81.90 | 103.57 |
| Price-to-Sales (P/S) Ratio | 8.53 | 12.39 | 10.04 | 8.11 | 7.92 |
| Price-to-Book (P/B) Ratio | 22.24 | 27.56 | 18.26 | 13.81 | 12.48 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6047.66 | 333.75 | 759.88 | 163.39 | 69.97 |
| Price-to-Operating Cash Flow Ratio | 2846.48 | 324.82 | 466.51 | 139.51 | 63.29 |
| Price-to-Earnings Growth (PEG) Ratio | 1.67 | -6.48 | 1.29 | 1.34 | -3.05 |
| Enterprise Value Multiple | 66.87 | 104.80 | 53.04 | 50.59 | 58.85 |
| Enterprise Value | 190.75B | 207.30B | 125.01B | 76.39B | 59.40B |
| EV to EBITDA | 66.87 | 104.80 | 53.04 | 50.59 | 58.85 |
| EV to Sales | 8.38 | 12.10 | 9.65 | 7.62 | 7.37 |
| EV to Free Cash Flow | 5942.37 | 325.88 | 730.60 | 153.48 | 65.14 |
| EV to Operating Cash Flow | 2796.92 | 317.16 | 448.53 | 131.05 | 58.93 |
| Tangible Book Value Per Share | 349.13 | 307.90 | 283.92 | 235.47 | 204.56 |
| Shareholders’ Equity Per Share | 349.13 | 308.16 | 284.77 | 235.48 | 204.56 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 |
| Revenue Per Share | 910.27 | 685.37 | 518.21 | 401.19 | 322.24 |
| Net Income Per Share | 75.01 | 46.30 | 64.60 | 39.72 | 24.64 |
| Tax Burden | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 |
| Interest Burden | 0.98 | 0.99 | 0.99 | 1.00 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 |
| SG&A to Revenue | 0.16 | 0.15 | 0.03 | 0.03 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.04 | 0.42 | 0.17 | 0.43 | 1.21 |
Currency in INR

